Autopsy report · NCT00562887
Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease
Cause of deathNo reason given
Life of this trial
- 246 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Abbott
- Sponsor type
- Industry
- Conditions
- Crohn's Disease
- Interventions
- Placebo; ABT-874; ABT-874
- Participants
- 246
- Sites
- 61
- Countries
- Australia, Austria, Belgium, Canada, Denmark, Puerto Rico, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.